510(k) Report

510(k) · Cleared

Cleared

Cedia Red Blood Cell Folate (NO Boil Reagent Pack)

K960800510(k) TraditionalCleared Jul 26, 1996150-day reviewClass II21 CFR 862.1295

Data to Oct 25, 2026 (FDA decisions) Oct 12, 2026 (recalls) Sep 30, 2026 (MAUDE) refreshed weekly, last Nov 3, 2026

Boehringer Mannheim Corp. · CGN Acid, Folic, Radioimmunoassay

Cleared on Jul 26, 1996 after a 150-day review. The FDA summary names its predicate without a number.

Decided
Jul 26, 1996
Review
150 days
Class
Class II
Product code
CGN
Recalls
None
Predicates
0

The FDA summary names its predicate without a number.

FIG. 1 — Lineage of K960800Source: FDA 510(k) database · How lineage is built

Get the monthly Device Review Tracker

Notable FDA decisions, review times and new Class I recalls. See an issue.

Sources: FDA 510(k) database (decision fields), the FDA summary (predicates and indications), FDA recall and enforcement reports, and MAUDE; processed by 510(k) Report. Verify on FDA.gov · Methodology and accuracy.

Planning a device in CGN? A 510(k) Report weighs predicate choices, recall history and review times for a new device like this one.

Top candidate predicates for a new CGN device

  1. #1 K233060 Elecsys Folate IIIscore 9.9 · 9 generations · no Class I recall
  2. #2 Held for the reportin the report
  3. #3 Held for the reportin the report
Get a 510(k) Report

What was it cleared against? (1)

Devices the submitter claimed this one is substantially equivalent to (*), and reference devices cited for a specific test or feature (†), as written in the FDA summary.

TypeNumberDeviceApplicantDecidedRecalls
*—CEDIA® Red Blood Cell Folate Reagent Pack
Named without a submission number
—

What descends from it?

No later submission names this one as a predicate yet.

Has anything in its family been recalled? (0 Class I)

No FDA recall names this device.

No ancestor or descendant has a Class I recall.

How does its category compare?

All CGN devices

CGN Acid, Folic, Radioimmunoassay: FDA decisions, review times, recalls and adverse event reports over 20 years.

FDA decisions per year · CGN

1in 2024

2009: 22010: 12011: 12014: 12016: 12018: 12020: 12023: 12024: 1
2007high 2 (2009) · low 0 (2007)2026

2026 to Oct 25, outlined.

Median 510(k) review, days · CGN

Too few CGN 510(k)s in any year since 2007 to give a median.

Recalls per year · CGN

3in 2019

2007: 22008: 12009: 12010: 12012: 22013: 12018: 22019: 3
2007high 3 (2019) · low 0 (2011)2026

Class I (0 since 2007) Class II/III not classified

Adverse event reports per year · CGN

9in 2025

2007: 262009: 32011: 282012: 112013: 22014: 42015: 12016: 42017: 62018: 22019: 12020: 52021: 32022: 132023: 82024: 192025: 9
2007high 28 (2011) · low 0 (2008)2025

MAUDE reports naming product code CGN, not matched to any one device; reports are not rates.

View these four charts as a table
YearDecisionsMedian 510(k) review, daysRecalls (Class I)MAUDE reports
20070—226
20080—10
20092—13
20101—10
20111—028
20120—211
20130—12
20141—04
20150—01
20161—04
20170—06
20181—22
20190—31
20201—05
20210—03
20220—013
20231—08
20241—019
20250—09
20260—0—

What is it indicated for?

The CEDIA® Red Blood Cell Folate (No Boil) Reagent Pack to be used in combination with the CEDIA® Folate (No Boil) Assay is a homogeneous enzyme binding assay for the quantitation of folate in red blood cells.

Indications for use read by OCR from a scanned FDA summary, so letters may be misread. Check the PDF before quoting it.

Cite this page

510(k) Report. “K960800: Cedia Red Blood Cell Folate (NO Boil Reagent Pack).” Lineage record from FDA 510(k) data and the FDA summary. Updated Nov 3, 2026. Accessed Nov 6, 2026. https://510kreport.com/device/K960800

Report an extraction error

Tell us what is wrong; we check it against the FDA summary.

Are you the manufacturer?

Send a correction or an update to this page, for example a newer model or a public statement about a recall.

Record history
  • FDA decision record loaded May 2, 2026
  • Summary read Oct 13, 2026 (extraction version 9eaa42aa01ed)
  • Page last updated Nov 3, 2026